Term ends Mar 26, 2035 · High confidence
20-year base term ends Mar 13, 2035
Held by Novartis AG
Filed Dec 1, 2017 as application 15/829,284 · Granted Jul 14, 2020
Base term plus 13 days of patent term adjustment (USPTO delay)
Today
2015
2035
Clock starts
Mar 13, 2015
Mar 13, 2015
Term ends
Mar 26, 2035
Mar 26, 2035
Granted
Jul 14, 2020
Jul 14, 2020
base term
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
13
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 13 days past its 20-year base term on prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 13, 2015, when application 14/657,260, the earliest non-provisional in its chain, was filed (this one was filed Dec 1, 2017) | Mar 13, 2035 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +13 days, USPTO patent term adjustment record | Mar 26, 2035 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 26, 2035 | High confidence |
This family
| Application 14/657,260 | Abandoned not computed | not computed |
| US 9,908,936 | In force Mar 2035 | Mar 2035 |
| US 10,711,060 | this patent Mar 2035 | Mar 2035 |
| US 12,252,535 | In force Mar 2035 | Mar 2035 |
| Application 19/024,582 | Pending not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 3, 2018 Reel 46061, frame 526 | Immutep S.A. | Immutep S.A.S. | Change of Name |
| May 3, 2018 Reel 45703, frame 723 | Triebel, Frédéric; Brignone, Chrystelle | Immutep S.A. | Assignment of Assignor's Interest |
| May 3, 2018 Reel 45703, frame 784 | Blattler, Walter A.; Mataraza, Jennifer Marie; Sabatos-peyton, Catherine Anne | Costim Pharmaceuticals Inc. | Assignment of Assignor's Interest |
| May 3, 2018 Reel 45703, frame 750 | Chang, Hwai Wen; Frey, Gerhard Johann | BioAtla, LLC | Assignment of Assignor's Interest |
| May 3, 2018 Reel 45703, frame 797 | BioAtla, LLC | Costim Pharmaceuticals Inc. | Assignment of Assignor's Interest |
| May 3, 2018 Reel 45703, frame 805 | Costim Pharmaceuticals Inc. | Novartis AG | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Mar 2035
Term ends Mar 26, 2035. Maintenance fees still fall due before then
Note
The 13 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
20
later US patents cite this one
That is top 10% of utility patents granted in 2020 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.